Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 12, 2019 07:00 ET | Source: Immuron Limited

US Department of Defense Reports Final Results from Travelan® Shigellosis Challenge Study

Key Highlights: Travelan® shigellosis challenge studies in non-human primates successfully completedTravelan® prevented clinical shigellosis (bacillary dysentery) in 75% of Travelan® treated animals...
June 23, 2016 09:07 ET | Source: Immuron Limited

Immuron Signs Shigella Vaccine Development Agreement with US Army

MELBOURNE, Australia, June 23, 2016 (GLOBE NEWSWIRE) -- Australian microbiome biopharmaceutical company Immuron Limited (ASX:IMC) (OTCQB:IMROY), is pleased to announce that the Company has...